This legislation, titled the Health Care Price Certainty for All Americans Act, aims to significantly enhance price transparency across the healthcare system. It establishes new requirements for various healthcare providers and health insurance entities to disclose pricing information to both the public and individual consumers. The bill seeks to empower patients with better information to make informed decisions about their care and costs. Beginning January 1, 2027, hospitals participating in Medicare must publicly disclose all standard charges, including gross charges, payer-specific negotiated charges, and discounted cash prices, in machine-readable and consumer-friendly formats. They must also provide prices for at least 300 shoppable services and attest annually to the completeness and accuracy of this information. Hospitals maintaining a price estimator tool that meets specific criteria may be deemed compliant for shoppable services. Effective January 1, 2028, similar price transparency requirements are extended to clinical diagnostic laboratories , providers of imaging services , and ambulatory surgical centers . These entities must make publicly available discounted cash prices or gross charges for specified services, update this information annually, and submit attestations of accuracy. The Secretary of Health and Human Services is tasked with establishing uniform methods and formats for these disclosures. The bill establishes robust monitoring and enforcement mechanisms for provider compliance, including civil monetary penalties. For hospitals, penalties can range from $342 to $6,277 per day, with significantly higher fines for persistent non-compliance, potentially reaching up to $10 million. Penalties for other providers are set at up to $300 per day. The Secretary can waive or reduce penalties for rural or underserved areas, or in cases of hardship like natural disasters, and must publicly report compliance and enforcement activities. For group health plans and health insurance issuers , starting January 1, 2029, new requirements for cost-sharing transparency will be in effect. They must provide participants and beneficiaries with timely, individualized information on their out-of-pocket costs for specific items and services upon request. This includes deductibles, copayments, coinsurance, and prior authorization requirements, accessible through self-service tools or other specified formats. Furthermore, these plans and issuers must publicly disclose detailed rate and payment information in machine-readable files on a quarterly basis. This includes in-network rates for items and services, average amounts paid for prescription drugs (accounting for rebates and discounts), and billed/allowed amounts for out-of-network services. The bill also mandates a summary data file of all rate and payment information annually, and requires attestations of compliance and accuracy from plan officials. The legislation also addresses vertical integration accountability within Medicare Advantage (MA) and Prescription Drug Plans (PDPs). Starting in 2028, MA organizations and PDP sponsors must report information on healthcare providers and pharmacies that are owned by, controlled by, or have specific financial arrangements with them. This data will be used by the Medicare Payment Advisory Commission to assess the impact of vertical integration on healthcare access, price, quality, and outcomes. Finally, the bill prohibits health plans and pharmacy benefit managers from restricting pharmacies from informing patients about lower cash prices for prescription drugs compared to their insurance co-pays. It also appropriates $100 million for the Secretaries of Health and Human Services, Treasury, and Labor to implement and enforce these provisions, and mandates several reports to Congress on API use, provider tools, compliance, price trends, and quality metrics.